Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
57.1M
-
Number of holders
-
204
-
Total 13F shares, excl. options
-
51.7M
-
Shares change
-
+318K
-
Total reported value, excl. options
-
$1.82B
-
Value change
-
+$16.4M
-
Put/Call ratio
-
0.79
-
Number of buys
-
117
-
Number of sells
-
-104
-
Price
-
$35.19
Significant Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q2 2023
252 filings reported holding HRMY - Harmony Biosciences Holdings, Inc. - Common Stock as of Q2 2023.
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) has 204 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.7M shares
of 57.1M outstanding shares and own 90.58% of the company stock.
Largest 10 shareholders include Valor Management LLC (11.2M shares), BlackRock Inc. (5.75M shares), FMR LLC (5.47M shares), VANGUARD GROUP INC (3.6M shares), Vivo Capital, LLC (2.61M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.2M shares), STATE STREET CORP (1.14M shares), venBio Partners LLC (1.04M shares), MACQUARIE GROUP LTD (902K shares), and PERCEPTIVE ADVISORS LLC (891K shares).
This table shows the top 204 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.